about
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where ...
Read More
2.00
0.00
(0.00%)
67,679.7
XNAS Volume
XNAS 17 Jul, 2026 11:10 AM (EDT)
Board Meeting
The latest board meeting for Entera Bio Ltd took place on 16 Jul 2026, for the purpose of Entera Bio Ltd Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Entera Bio Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..